Lower segment uterine scar rupture during induction of labour with vaginal prostaglandin E2.

Induction of labour using prostaglandin E2 pessaries.

The blanket use of prostaglandin E2 pessaries, as reported by Mr J H Shepherd and his colleagues (14 July, p 108), does concern me. While they did draw attention to the need for fetal monitoring in such patients, I wonder how satisfactorily this can be achieved, especially in relatively high-risk cases, under such circumstances and whether such monitoring could not be better achieved by direct...

Spasmodic Contraction of the Lower Uterine Segment during Labour

Report of A Case of Uterine Rupture in Pregnant Women Without Scar After Vaginal Delivery

Background: Uterine rupture in pregnancy and labour is a fetal complication. Prevalence of uterine rupture in pregnancy in women with no previous uterine scare specially, nulliparous women without any risk is rare. Risk factors of uterine rupture in women with no previous scare are such as trauma, obstetrics maneuvers, high parity, multiple babies and uterotonic agents. Casa Presentation: A 23 ...

Induction of labour with a sustained-release prostaglandin E2 vaginal pessary.

A new polymer vaginal pessary providing sustained constant release of prostaglandin E2 was administered to 66 patients before planned induction of labour. Effective ripening of the unfavourable cervix was achieved in each of 18 primigravidas, in eight of whom labour was initiated without further treatment. When the cervix was moderately favourable the need for orthodox induction of labour was o...

A Comparison of Oral Misoprostol and Vaginal Prostaglandin E2 Tablets for Induction of Labour at Term

Objective: To compare the efficacy and safety of oral misoprostol with prostaglandin E2 vaginal tablets for ripening of cervix and induction of labour at term. Study Design: A non blinded, randomised, controlled trial. Place and Duration of Study: Department of Obstetrics and Gynaecology, Pakistan Air Force Hospital, Air Headquarters Islamabad from July 2005 to January 2006. Patients and Method...